Mergers and Acquisitions - Pfizer to acquire weight-loss drug developer Metsera for up to $73 billion [1] Market Focus - Pfizer re-enters the growing obesity drug market [1]

As evidence mounts on the potential health benefits of obesity drugs like Wegovy and Zepbound, so do the barriers to access, @lisamjarvis says (via @opinion) https://t.co/biDmqyWZ1k ...